Filing Details
- Accession Number:
- 0001127602-16-059802
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-09 09:23:11
- Reporting Period:
- 2016-08-05
- Filing Date:
- 2016-08-09
- Accepted Time:
- 2016-08-09 09:23:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1472091 | Edge Therapeutics Inc. | EDGE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1214501 | Bradford W Middlekauff | 200 Connell Drive Suite 1600 Berkeley Heights NJ 07922 | Senior Vp, Gc And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-08-05 | 9,857 | $9.48 | 9,857 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-08-08 | 143 | $9.43 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $9.42 to $9.60 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.